Level Bio AB Statistics

Total Valuation

Level Bio AB has a market cap or net worth of SEK 21.75 million. The enterprise value is 20.18 million.

Market Cap	21.75M
Enterprise Value	20.18M

Important Dates

The next estimated earnings date is Friday, February 20, 2026.

Earnings Date	Feb 20, 2026
Ex-Dividend Date	n/a

Share Statistics

Level Bio AB has 68.40 million shares outstanding. The number of shares has increased by 1.93% in one year.

Current Share Class	68.40M
Shares Outstanding	68.40M
Shares Change (YoY)	+1.93%
Shares Change (QoQ)	-5.53%
Owned by Insiders (%)	16.23%
Owned by Institutions (%)	13.88%
Float	32.03M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.72
PB Ratio	12.57
P/TBV Ratio	85.97
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-5.29
EV / Sales	0.66
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.03

Current Ratio	1.03
Quick Ratio	0.57
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-39.82

Financial Efficiency

Return on equity (ROE) is -104.88% and return on invested capital (ROIC) is -70.14%.

Return on Equity (ROE)	-104.88%
Return on Assets (ROA)	-17.99%
Return on Invested Capital (ROIC)	-70.14%
Return on Capital Employed (ROCE)	-170.22%
Revenue Per Employee	3.04M
Profits Per Employee	-381,328
Employee Count	11
Asset Turnover	2.14
Inventory Turnover	3.67

Taxes

Income Tax	-352,095
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +17.92% in the last 52 weeks. The beta is 1.26, so Level Bio AB's price volatility has been higher than the market average.

Beta (5Y)	1.26
52-Week Price Change	+17.92%
50-Day Moving Average	0.36
200-Day Moving Average	0.34
Relative Strength Index (RSI)	44.32
Average Volume (20 Days)	31,766

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Level Bio AB had revenue of SEK 30.39 million and -3.81 million in losses. Loss per share was -0.06.

Revenue	30.39M
Gross Profit	16.30M
Operating Income	-4.08M
Pretax Income	-4.17M
Net Income	-3.81M
EBITDA	-2.94M
EBIT	-4.08M
Loss Per Share	-0.06

Full Income Statement

Balance Sheet

The company has 1.57 million in cash and n/a in debt, giving a net cash position of 1.57 million or 0.02 per share.

Cash & Cash Equivalents	1.57M
Total Debt	n/a
Net Cash	1.57M
Net Cash Per Share	0.02
Equity (Book Value)	1.73M
Book Value Per Share	0.03
Working Capital	355,000

Full Balance Sheet

Cash Flow

Operating Cash Flow	-309,570
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 53.64%, with operating and profit margins of -13.43% and -12.55%.

Gross Margin	53.64%
Operating Margin	-13.43%
Pretax Margin	-13.71%
Profit Margin	-12.55%
EBITDA Margin	-9.69%
EBIT Margin	-13.43%
FCF Margin	n/a

Dividends & Yields

Level Bio AB does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-1.93%
Shareholder Yield	-1.93%
Earnings Yield	-17.53%
FCF Yield	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	3